The Use of Population Pharmacokinetics in Drug Development
- 1 February 1996
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 30 (2), 81-93
- https://doi.org/10.2165/00003088-199630020-00001
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Practical experience and issues in designing and performing population pharmacokinetic/pharmacodynamic studiesEuropean Journal of Clinical Pharmacology, 1996
- A Two-Step Iterative Algorithm For Estimation In Nonlinear Mixed-Effect Models With An Evaluation In Population PharmacokineticsJournal of Biopharmaceutical Statistics, 1995
- Population Pharmacokinetic/Pharmacodynamic Methodology and Applications: A BibliographyBiometrics, 1994
- Results and validation of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine.Proceedings of the National Academy of Sciences of the United States of America, 1992
- Pharmacodynamic ModellingClinical Pharmacokinetics, 1991
- Population dose versus response of betaxolol and atenolol: A comparison of potency and variabilityClinical Pharmacology & Therapeutics, 1991
- Pharmacodynamics in cancer therapy.Journal of Clinical Oncology, 1990
- Study designs for dose-rangingClinical Pharmacology & Therapeutics, 1989
- Minimal modeling, partition analysis, and the estimation of insulin sensitivity.1980
- Estimation of population characteristics of pharmacokinetic parameters from routine clinical dataJournal of Pharmacokinetics and Biopharmaceutics, 1977